Basil was diagnosed with glaucoma over 20 years ago, faced worsening vision despite stable eye pressure and received two differing treatment plans. Seeking clarity, he turned to Val from Glaucoma Australia, whose guidance and support helped him confidently choose the step-by-step plan while feeling reassured throughout the process.
A detailed analysis of the LiGHT Trial confirms that selective laser trabeculoplasty (SLT) slows glaucoma progression by 29% compared to eye drops. The findings, supported highlight SLT’s ability to reduce vision loss and the need for surgery, prompting its inclusion in international glaucoma treatment guidelines.
Glaucoma Australia and its Patron, the Governor-General of Australia, Her Excellency the Honourable Samantha Mostyn, are pleased to announce the 2024 recipient of the Glaucoma Australia ‘Quinlivan’ Research Grant.
Suzanne learned she had glaucoma during an eye check-up when she was 65. Now, for the past five years, she has been receiving treatment to protect her eyes from further damage.
A/Prof Owen Siggs, recipient of the Glaucoma Australia ‘Quinlivan’ Research Grant in 2022 is now 18 months into his research into the Genomic Risk Stratification to improve glaucoma suspect triage in rural primary care.
Glaucoma Australia recently hosted a congenital glaucoma brunch at the Currumbin Wildlife Sanctuary Gold Coast and what a memorable day it was!
Abbie was diagnosed with glaucoma as a newborn and had surgeries to control her eye pressure. Despite being short-sighted with nystagmus, she lives independently and runs a dance company called Blindful.
Leaving a gift in your Will is a spark of generosity that will continue beyond our lifetime. It allows us to invest in the research that will one day find a cure and continue to support families impacted by glaucoma.
AI is set to revolutionise the way doctors and patients interact with ophthalmic healthcare, with several published diagnostic AI models already boasting performance on par with eye specialists in the detection of diabetic retinopathy, macular degeneration, and glaucoma.